Search research articles
Contact Us
Filters
Showing results (161-170 of 315) with videos related to
Page
of 32
Sort By:
The Journal of Investigative Dermatology
|
June 29, 2005
Cell death-induced activation of epidermal growth factor receptor in keratinocytes: implications for restricting epidermal damage in dermatitis
Mihail S Iordanov, Aaron J Sundholm, Eric L Simpson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
August 10, 2018
Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults
Jonathan I Silverberg, Zelma C Chiesa Fuxench, Joel M Gelfand, et al.
Dermatology and Therapy
|
March 22, 2021
Relationship Among Treatment, Pruritus, Investigator's Static Global Assessment, and Quality of Life in Patients with Atopic Dermatitis
Eric L Simpson, Wynnis L Tom, Andrew G Bushmakin, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 23, 2019
Pain Is a Common and Burdensome Symptom of Atopic Dermatitis in United States Adults
Jonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
American Journal of Clinical Dermatology
|
August 18, 2021
Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes
Jonathan I Silverberg, Jacob P Thyssen, Eric L Simpson, et al.
Journal of the American Academy of Dermatology
|
December 27, 2022
Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies
Kim Papp, Jacek C Szepietowski, Leon Kircik, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
June 27, 2021
Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies
Brian S Kim, Jonathan I Silverberg, Sonja Ständer, et al.
Journal of the American Academy of Dermatology
|
December 28, 2025
Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): results from a randomized placebo-controlled trial
Eric L Simpson, Marie-Louise A Schuttelaar, Sonja Molin, et al.
American Journal of Clinical Dermatology
|
May 14, 2024
Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study
Amy S Paller, Elaine C Siegfried, Eric L Simpson, et al.
Dermatology and Therapy
|
July 22, 2023
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years
Elaine C Siegfried, Eric L Simpson, Michael J Cork, et al.
Page
of 32
Search research articles
Search
Showing results (161-170 of 315) with videos related to
Sort By:
Page
of 32
The Journal of Investigative Dermatology
|
June 29, 2005
Cell death-induced activation of epidermal growth factor receptor in keratinocytes: implications for restricting epidermal damage in dermatitis
Mihail S Iordanov, Aaron J Sundholm, Eric L Simpson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
August 10, 2018
Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults
Jonathan I Silverberg, Zelma C Chiesa Fuxench, Joel M Gelfand, et al.
Dermatology and Therapy
|
March 22, 2021
Relationship Among Treatment, Pruritus, Investigator's Static Global Assessment, and Quality of Life in Patients with Atopic Dermatitis
Eric L Simpson, Wynnis L Tom, Andrew G Bushmakin, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
June 23, 2019
Pain Is a Common and Burdensome Symptom of Atopic Dermatitis in United States Adults
Jonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
American Journal of Clinical Dermatology
|
August 18, 2021
Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes
Jonathan I Silverberg, Jacob P Thyssen, Eric L Simpson, et al.
Journal of the American Academy of Dermatology
|
December 27, 2022
Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies
Kim Papp, Jacek C Szepietowski, Leon Kircik, et al.
Dermatitis : Contact, Atopic, Occupational, Drug
|
June 27, 2021
Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies
Brian S Kim, Jonathan I Silverberg, Sonja Ständer, et al.
Journal of the American Academy of Dermatology
|
December 28, 2025
Dupilumab treatment improves health-related quality of life in patients with moderate-to-severe atopic dermatitis primarily affecting the hands (atopic hand eczema): results from a randomized placebo-controlled trial
Eric L Simpson, Marie-Louise A Schuttelaar, Sonja Molin, et al.
American Journal of Clinical Dermatology
|
May 14, 2024
Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study
Amy S Paller, Elaine C Siegfried, Eric L Simpson, et al.
Dermatology and Therapy
|
July 22, 2023
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years
Elaine C Siegfried, Eric L Simpson, Michael J Cork, et al.
Page
of 32